Quantbot Technologies LP Trims Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Quantbot Technologies LP decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 79.5% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,062 shares of the medical equipment provider’s stock after selling 15,763 shares during the period. Quantbot Technologies LP’s holdings in Intuitive Surgical were worth $2,120,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $31,000. Finally, Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $36,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $492.49 on Monday. The business’s fifty day moving average price is $562.24 and its 200-day moving average price is $532.03. The stock has a market capitalization of $175.41 billion, a price-to-earnings ratio of 76.83, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of analyst reports. Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Erste Group Bank cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Bernstein Bank boosted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Raymond James upped their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock worth $17,691,621 in the last three months. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.